Borealis Biosciences

BiotechnologySeries AVancouver, Canadaborealisbio.com

Latest round

Series A

Last raised

Dec 2024

Total raised

$180M

Investors

3

About Borealis Biosciences

Founded in 2024 by David Powell, and based in British Columbia, Canada, Borealis Biosciences, Inc. operates as a biotechnology research company that develops RNA drugs for treating kidney diseases. Borealis Biosciences is a company focused on developing RNA medicines to address kidney diseases and potentially other conditions. It was established based on the belief that recent scientific and translational advancements make RNA-based therapies viable for treating these diseases. The company is supported by Versant Ventures and Novartis AG, with whom it has a strategic collaboration.

Who invested in Borealis Biosciences

3 investors across 2 rounds

See all investors in Borealis Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 19, 2024

    Amount

    $30M

    Investors

    Locked

  2. Series A

    Aug 22, 2024

    Amount

    $150M

    Investors

    Locked

Questions about Borealis Biosciences

Who invested in Borealis Biosciences?

Borealis Biosciences has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Borealis Biosciences raised?

Borealis Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Borealis Biosciences last raise money?

Borealis Biosciences's most recent round on record is a Series A, in Dec 2024.

What does Borealis Biosciences do?

Founded in 2024 by David Powell, and based in British Columbia, Canada, Borealis Biosciences, Inc.

Where is Borealis Biosciences headquartered?

Borealis Biosciences is headquartered in Vancouver, Canada.

Which VCs invest in companies like Borealis Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Borealis Biosciences's stage. Their profiles are linked below.

Raising like Borealis Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.